Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
"Prostate Cancer" News  |<  Page 1  >> 
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

AstraZeneca to sell antibiotics business business to Pfizer Inc

Shares in UK drugs major AstraZeneca PLC (LON:AZN)  went lower in early deals as it struck a deal to sell part of its antibiotics business to US group Pfizer (NYSE:PFE) for up to US$1.575bn. The deal..
Proactive Investors

A Molecule May Help Distinguish Prostate Cancer Treatment Options - Dr. David Samadi Explains How

Scientists found that differences in the levels of an RNA molecule called PCAT-14A may help differentiate slow-growing tumors from aggressive tumors helping physicians more accurately decide the..
PRWeb

Videos for "Prostate Cancer"

News video: Morning Business Report: Stopping Robo Calls

Morning Business Report: Stopping Robo Calls

Morning Business Report: Stopping Robo Calls
Source: WMGT -

News video: Pfizer to acquire cancer drug maker Medivation, and other MoneyWatch headlines

Pfizer to acquire cancer drug maker Medivation, and other MoneyWatch headlines 01:08

Pfizer buying prostate cancer specialist Medivation for $14B; ex-NBA star Kobe Bryant to launch venture capital fund; and heavy flooding threatens U.S. rice harvest. These headlines and more from CBS..
Source: CBS News -

News video: Pfizer to buy Medivation for $14 billion

Pfizer to buy Medivation for $14 billion 01:04

Pfizer is paying a hefty premium for the much sought-after prostate cancer drug maker, Medivation. Fred Katayama reports.
Source: Rumble -

News video: Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy 01:26

A potential blockbuster drug deal is reportedly in the works. Several reports out today say Pfizer (PFE) is close to buying cancer drug company Medivation (MDVN) for $14 billion. It would be an..
Source: The Street -

News video: SEA Blue Cancer Walk

SEA Blue Cancer Walk

SEA Blue Cancer Walk
Source: WROC -

 

Manhattan Beach Man Races to Bring Awareness to Prostate Cancer

manhattan beach man races to bring awareness to prostate cancer
Patch Manhattan Beach, CA -- More than 29,000 men die of the disease each year.
Patch

Mount Sinai Establishes Center for Computational and Systems Pathology

Researchers will contribute cutting-edge innovation in personalized precision medicine New York, NY (PRWEB) August 23, 2016 The Department of Pathology at the Icahn School of Medicine at Mount..
PRWeb

First DRP selected Breast Cancer Patient obtained reduction of tumor by LiPlaCis treatment

* *Hoersholm, Denmark; August 23rd, 2016 - Medical Prognosis Institute A/S (MPI:ST) announces that the first patient with metastatic Breast Cancer included in the extension - proof of concept part of..
GlobeNewswire

Pfizer boosts cancer drug roster with $14 billion Medivation deal

Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the..
Zee News Also reported by •ReutersReuters India

Business Highlights

Yet with less than three months to go before Election Day, the values of young Americans whose coming-of-age was bookended by the Sept. 11, 2001, terrorist attacks and the Great Recession are emerging..
SeattlePI.com

Pfizer raid on cancer drug developer Medivation to spark takeovers in drugs sector

pfizer raid on cancer drug developer medivation to spark takeovers in drugs sector
The deal follows months of speculation about possible suitors for San Francisco-based Medivation, which produces prostate cancer treatment Xtandi.
MailOnline Also reported by •thisismoney.co.uk

Tokai Pharma in flux with lead product candidate galeterone, enrollment in mid-stage prostate cancer study nixed; shares slump 23% after hours


SeekingAlpha

Pfizer to buy cancer-drug maker Medivation for $14 billion

Pfizer’s $14 billion deal to buy San Francisco’s Medivation Inc. adds a blockbuster prostate-cancer drug to the pharmaceutical giant’s roster of drugs and strengthens its line of lucrative cancer..
SFGate Also reported by •San Jose Mercury News

Sanders to Pfizer: Lower 'unconscionable' drug prices

Bernie Sanders took to Twitter to voice his reaction to Pfizer's announcement that it's buying Medivation -- a pharmaceutical company that developed a drug that treats prostate cancer that costs six..
CNNMoney

Pfizer to acquire cancer drug maker Medivation, and other MoneyWatch headlines

Pfizer buying prostate cancer specialist Medivation for $14B; ex-NBA star Kobe Bryant to launch venture capital fund; and heavy flooding threatens U.S. rice harvest. These headlines and more from CBS..
CBS News

Papers: Tyra Banks to teach course at Stanford Business School

Pfizer has agreed to buy biotech Medivation Inc for about US$14bn. The deal ends months of bidding for San Francisco’s Medivation, one of the most desired independent biotechs because it sells a..
Proactive Investors

Here's why Pfizer spent $14 billion on a company with just one approved drug (MDVN, PFE)

here's why pfizer spent $14 billion on a company with just one approved drug (mdvn, pfe)
Pfizer just outbid a number of competitors for Medivation, a cancer drugmaker with just one approved drug. The $14 billion deal, at $81.50 per share, is a notable premium to the $9.3 billion offer..
Business Insider

Pfizer confirms, Medivation to be acquired for $14 billion

Pfizer will purchase biotech firm Medivation, which specialises in cancer treatments, for some US $14 billion, the US pharma giant said in a statement on Monday. Pfizer's offer for the San..
DNA

Pfizer wins battle for Medivation with US$14bn offer

Shares in Medivation (NASDAQ:MDVN) surged 20% as Pfizer (NYSE:PFE) confirmed it had agreed to buy the cancer drug developer for US$14bn. Widely flagged over the weekend, the deal adds the blockbuster..
Proactive Investors

Pfizer to buy Medivation and boost cancer drug portfolio

Pfizer has outbid Sanofi to buy the US cancer drug company Medivation, thereby acquiring the prostate cancer treatment Xtandi.
euronews

You Might Like


 |<  Page 1  >> 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2016 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+